A case of subacute cutaneous lupus erythematosus as a result of ranibizumab (Lucentis) treatment

Cutaneous lupus erythematosus is a previously undiagnosed side-effect of ranibizumab. Here, we present a case of an 82-year-old female Caucasian patient with wet age-related macular degeneration. Following a single intraocular injection of Lucentis (ranibizumab), she developed a subacute cutaneous l...

Descripción completa

Detalles Bibliográficos
Autores principales: Andric, Marko, Dixit, Shreya, Robaei, Dana, Watchorn, Rosemary, Verma, Nitin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Ophthalmology Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3917396/
https://www.ncbi.nlm.nih.gov/pubmed/24212210
http://dx.doi.org/10.4103/0301-4738.121133
_version_ 1782302833488429056
author Andric, Marko
Dixit, Shreya
Robaei, Dana
Watchorn, Rosemary
Verma, Nitin
author_facet Andric, Marko
Dixit, Shreya
Robaei, Dana
Watchorn, Rosemary
Verma, Nitin
author_sort Andric, Marko
collection PubMed
description Cutaneous lupus erythematosus is a previously undiagnosed side-effect of ranibizumab. Here, we present a case of an 82-year-old female Caucasian patient with wet age-related macular degeneration. Following a single intraocular injection of Lucentis (ranibizumab), she developed a subacute cutaneous lupus erythematosus which, with treatment, took nearly 12 months to resolve. This shows that cutaneous lupus erythematosus is a potential side-effect of many medications, including ranibizumab, as in our case and, in an aging population where polypharmacy is a growing reality, clinicians should be aware of how to diagnose and best manage such cases.
format Online
Article
Text
id pubmed-3917396
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-39173962014-02-19 A case of subacute cutaneous lupus erythematosus as a result of ranibizumab (Lucentis) treatment Andric, Marko Dixit, Shreya Robaei, Dana Watchorn, Rosemary Verma, Nitin Indian J Ophthalmol Ophthalmology Practice Cutaneous lupus erythematosus is a previously undiagnosed side-effect of ranibizumab. Here, we present a case of an 82-year-old female Caucasian patient with wet age-related macular degeneration. Following a single intraocular injection of Lucentis (ranibizumab), she developed a subacute cutaneous lupus erythematosus which, with treatment, took nearly 12 months to resolve. This shows that cutaneous lupus erythematosus is a potential side-effect of many medications, including ranibizumab, as in our case and, in an aging population where polypharmacy is a growing reality, clinicians should be aware of how to diagnose and best manage such cases. Medknow Publications & Media Pvt Ltd 2013-12 /pmc/articles/PMC3917396/ /pubmed/24212210 http://dx.doi.org/10.4103/0301-4738.121133 Text en Copyright: © Indian Journal of Ophthalmology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Ophthalmology Practice
Andric, Marko
Dixit, Shreya
Robaei, Dana
Watchorn, Rosemary
Verma, Nitin
A case of subacute cutaneous lupus erythematosus as a result of ranibizumab (Lucentis) treatment
title A case of subacute cutaneous lupus erythematosus as a result of ranibizumab (Lucentis) treatment
title_full A case of subacute cutaneous lupus erythematosus as a result of ranibizumab (Lucentis) treatment
title_fullStr A case of subacute cutaneous lupus erythematosus as a result of ranibizumab (Lucentis) treatment
title_full_unstemmed A case of subacute cutaneous lupus erythematosus as a result of ranibizumab (Lucentis) treatment
title_short A case of subacute cutaneous lupus erythematosus as a result of ranibizumab (Lucentis) treatment
title_sort case of subacute cutaneous lupus erythematosus as a result of ranibizumab (lucentis) treatment
topic Ophthalmology Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3917396/
https://www.ncbi.nlm.nih.gov/pubmed/24212210
http://dx.doi.org/10.4103/0301-4738.121133
work_keys_str_mv AT andricmarko acaseofsubacutecutaneouslupuserythematosusasaresultofranibizumablucentistreatment
AT dixitshreya acaseofsubacutecutaneouslupuserythematosusasaresultofranibizumablucentistreatment
AT robaeidana acaseofsubacutecutaneouslupuserythematosusasaresultofranibizumablucentistreatment
AT watchornrosemary acaseofsubacutecutaneouslupuserythematosusasaresultofranibizumablucentistreatment
AT vermanitin acaseofsubacutecutaneouslupuserythematosusasaresultofranibizumablucentistreatment
AT andricmarko caseofsubacutecutaneouslupuserythematosusasaresultofranibizumablucentistreatment
AT dixitshreya caseofsubacutecutaneouslupuserythematosusasaresultofranibizumablucentistreatment
AT robaeidana caseofsubacutecutaneouslupuserythematosusasaresultofranibizumablucentistreatment
AT watchornrosemary caseofsubacutecutaneouslupuserythematosusasaresultofranibizumablucentistreatment
AT vermanitin caseofsubacutecutaneouslupuserythematosusasaresultofranibizumablucentistreatment

Ejemplares similares